NCT05748249View on ClinicalTrials.gov

Evaluation of the Efficacy of Vertistop® D and Vertistop® L in the Prevention of BPPV Recurrence

PHASE1CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Benign Paroxysmal Positional VertigoVitamin DAntioxidants
Interventions
DRUG

Vertistop® D

Vitamin D supplementation

Trial Locations (1)

00168

Clinica Otorinolaringoiatrica, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05748249 - Evaluation of the Efficacy of Vertistop® D and Vertistop® L in the Prevention of BPPV Recurrence | Biotech Hunter | Biotech Hunter